comparemela.com

Latest Breaking News On - Clinical trials committee - Page 2 : comparemela.com

iOmx Therapeutics appoints Professor Frances Balkwill to the Scientific Advisory Board

iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on next-generation immune checkpoint targets, today announced the appointment of Frances Balkwill, Professor of Cancer Biology at Barts Cancer Institute, Queen Mary University of London, to its Scientific Advisory Board (SAB).

Bahrain remains among world s top performers on Nikkei s COVID-19 Recovery Index | THE DAILY TRIBUNE

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.